PRTG
CRDF icon

Post Resch Tallon Group’s Cardiff Oncology CRDF Stock Holding History

Post Resch Tallon Group’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.3K Hold
22,515
– – 0.02% 138
2026
Q1 		$38.5K Buy
22,515
+12
+0.1% +$25 0.03% 117
2025
Q4 		$63.2K Sell
22,503
-35
-0.2% -$81 0.05% 107
2025
Q3 		$46.4K Buy
+22,538
New +$62.3K 0.04% 109

Other funds holding CRDF

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
SA
Scarborough Advisors Annapolis, Maryland $871M AUM 21.96% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
LWA
Ledgewood Wealth Advisors Exeter, New Hampshire $188M AUM 18.45% 1-Year Est. Return
SNB
Security National Bank Omaha, Nebraska $838M AUM 39.07% 1-Year Est. Return
TCOT
Trust Company of Toledo Holland, Ohio $1.2B AUM 33.38% 1-Year Est. Return
GSWM
Golden State Wealth Management Santa Ana, California $1.1B AUM 27.49% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Post Resch Tallon Group's CRDF Position: Q2 2026 in Review

Post Resch Tallon Group held its Cardiff Oncology (CRDF) position steady in Q2 2026 at 22,515 shares worth $29.3K. The position accounts for 0.02% of the portfolio, ranked #138.

Post Resch Tallon Group first reported a position in CRDF in Q3 2025 and has held it in 4 quarters since. The position peaked at $63.2K in Q4 2025. 15 funds tracked by Wall St. Rank hold CRDF as of Q2 2026.

  • Post Resch Tallon Group held 22,515 shares of Cardiff Oncology worth $29.3K as of Q2 2026.
  • Post Resch Tallon Group left its Cardiff Oncology share count unchanged in Q2 2026.
  • Cardiff Oncology made up 0.02% of Post Resch Tallon Group's portfolio in Q2 2026, its #138 holding.
  • Post Resch Tallon Group first reported a position in Cardiff Oncology in Q3 2025 and has held it in 4 quarters since.
  • Post Resch Tallon Group's Cardiff Oncology position peaked at $63.2K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2026.

Based on Post Resch Tallon Group's 13F filing for Q2 2026, filed 7 Jul 2026.